切换至 "中华医学电子期刊资源库"

中华脑血管病杂志(电子版) ›› 2023, Vol. 17 ›› Issue (02) : 145 -149. doi: 10.11817/j.issn.1673-9248.2023.02.010

综述

脑小血管病总负担评估量表的研究进展
胡红梅1, 胡文立1,()   
  1. 1. 100020 首都医科大学附属北京朝阳医院神经内科
  • 收稿日期:2022-08-22 出版日期:2023-04-01
  • 通信作者: 胡文立
  • 基金资助:
    国家自然科学基金项目(81271309)

Research progress in total burden assessment scale for cerebral small vessel disease

Hongmei Hu1, Wenli Hu1,()   

  1. 1. Department of Neurology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
  • Received:2022-08-22 Published:2023-04-01
  • Corresponding author: Wenli Hu
引用本文:

胡红梅, 胡文立. 脑小血管病总负担评估量表的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(02): 145-149.

Hongmei Hu, Wenli Hu. Research progress in total burden assessment scale for cerebral small vessel disease[J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2023, 17(02): 145-149.

随着对脑小血管病(CSVD)临床、影像和病理生理机制的不断深入研究发现,CSVD各影像标志物之间存在关联性,其互相影响并可对临床症状产生协同或叠加作用。越来越多的证据表明,CSVD与卒中复发、认知功能下降、运动障碍、情绪异常和二便障碍等密切相关,应被作为一种全脑性疾病来对待。本文就不同CSVD影像标志物负担的评估和临床意义,以及CSVD总负担评分方法的研究进展进行总结,以期对进一步改良总CSVD评分提供一定参考。

With the in-depth study of the clinical, imaging, and pathophysiological mechanism of cerebral small vessel disease (CSVD) , it was found that the various imaging markers of CSVD were interrelated and interacted with each other, and they might have synergistic or superimposed effects on the clinical symptoms. Increasing evidence showed that CSVD was closely related to stroke recurrence, cognitive decline, dyskinesia, emotional abnormality, dysuria, and defecation disorder, which should therefore be treated as a whole brain disease. We reviewed the evaluation and clinical significance of CSVD imaging markers together with the research progress of CSVD total burden scoring methods, in order to provide some reference for further improvement of CSVD total burden score.

表1 不同研究下CSVD总负担评分方法
序号 文献 WMH CMBs EPVS 腔隙 急性腔隙性梗死 脑萎缩 皮质表面铁沉积 总分(分)
1 Kim等 [3] PWMH≥3或DWMH≥2,1分 深部CMBs≥1个,1分 - ≥1个,1分 ≥1个,1分 - - 0~4
2 Hong等 [11] 中度WMH(总分3~4),1分;重度WMH(总分5~6),2分 1~4个,1分;≥5个,2分 BG-EPVS 11~20个,1分;BG-EPVS>20个,2分 ≥1个,1分 - - - 0~7
中度WMH(总分3~4),1分;重度WMH(总分5~6),2分 1~4个,1分;≥5个,2分 (BG/CSO)-EPVS 11~20个,1分;(BG/CSO)-EPVS>20个,2分 ≥1个,1分 - - -
3 Zhi等 [12] 中度WMH(总分3~4分),1分;重度WMH(总分5~6分),2分 1~4个深部CMBs,1分;≥5个深部CMBs,2分 BG-EPVS>20个,1分 ≥1个,1分 - - - 0~6
4 Molad等 [18] PWMH≥3或DWMH≥2,1分 ≥1个,1分 (BG+CSO)-EPVS≥30个,1分 ≥1个,1分 - - - 0~4
5 Xia等 [19] PWMH≥3或DWMH≥2,1分 ≥1个,1分 (BG/CSO)-EPVS>20个,1分 ≥1个,1分 - - - 0~4
6 Yang等[26] PWMH≥3或DWMH≥2,1分 深部CMBs≥1个,1分 BG-EPVS>10个,1分 ≥1个,1分 - 中重度,1分 - 0~5
7 Charidimou等 [31] PWMH≥3或DWMH≥2,1分 2~4个脑叶CMBs,1分;≥5个脑叶CMBs,2分 CSO-EPVS>20个,1分 - - - ≤3个脑沟;>3个脑沟,2分 0~6
8 Staals等 [34] PWMH≥3或DWMH≥2,1分 ≥1个,1分 BG-EPVS>10个,1分 ≥1个,1分 - - - 0~4
9 Xu等 [35] PWMH≥2或DWMH≥2,1分 ≥1个,1分 BG-EPVS>10个,1分 ≥1个,1分 - - - 0~4
1
Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration [J]. Lancet Neurol, 2013, 12(8): 822-838.
2
Huijts M, Duits A, van Oostenbrugge RJ, et al. Accumulation of MRI markers of cerebral small vessel disease is associated with decreased cognitive function. a study in first-ever lacunar stroke and hypertensive patients [J]. Front Aging Neurosci, 2013, 5: 72.
3
Kim YB, Park K, Chung P, et al. Brachial-ankle pulse wave velocity is associated with both acute and chronic cerebral small vessel disease [J]. Atherosclerosis, 2016, 245: 54-59.
4
Rudilosso S, Mena L, Esteller D, et al. Higher cerebral small vessel disease burden in patients with white matter recent small subcortical infarcts [J]. J Stroke Cerebrovasc Dis, 2021, 30(7): 105824.
5
Eppinger S, Gattringer T, Nachbaur L, et al. Are morphologic features of recent small subcortical infarcts related to specific etiologic aspects? [J]. Ther Adv Neurol Disord, 2019, 12: 1278057284.
6
Hong H, Zhang R, Yu X, et al. Factors associated with the occurrence and evolution of recent small subcortical infarcts (RSSIs) in different locations [J]. Front Aging Neurosci, 2020, 12: 264.
7
Cannistraro RJ, Badi M, Eidelman BH, et al. CNS small vessel disease: a clinical review [J]. Neurology, 2019, 92(24): 1146-1156.
8
Erkinjuntti T, Inzitari D, Pantoni L, et al. Research criteria for subcortical vascular dementia in clinical trials [J]. J Neural Transm Suppl, 2000, 59: 23-30.
9
苏小吏, 杨银雪, 岳卫东. 关键部位脑梗死与认知功能障碍的相关性分析 [J]. 阿尔茨海默病及相关病杂志, 2020, 3(3): 191-194.
10
de Laat KF, van Norden AGW, Gons RAR, et al. Gait in elderly with cerebral small vessel disease [J]. Stroke, 2010, 41(8): 1652-1658.
11
Xu M, Zhang S, Liu J, et al. Kidney dysfunction is associated with a high burden of cerebral small vessel disease in primary intracerebral hemorrhage [J]. Curr Neurovasc Res, 2018, 15(1): 39-46.
12
Zhi N, Zhang L, Wang Y, et al. Modified cerebral small vessel disease score is associated with vascular cognitive impairment after lacunar stroke [J]. Aging, 2021, 13(7): 9510-9521.
13
Park J, Kwon SU, Kwon HS, et al. Prior intracerebral hemorrhage and white matter hyperintensity burden on recurrent stroke risk [J]. Sci Rep, 2021, 11(1): 17406.
14
Lampe L, Kharabian-Masouleh S, Kynast J, et al. Lesion location matters: the relationships between white matter hyperintensities on cognition in the healthy elderly [J]. J Cereb Blood Flow Metab, 2019, 39(1): 36-43.
15
Hu HY, Ou YN, Shen XN, et al. White matter hyperintensities and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 36 prospective studies [J]. Neurosci Biobehav Rev, 2021, 120: 16-27.
16
Xing Y, Yang J, Zhou A, et al. Altered brain activity mediates the relationship between white matter hyperintensity severity and cognition in older adults [J]. Brain Imaging Behav, 2022, 16(2): 899-908.
17
Doubal FN, MacLullich AM, Ferguson KJ, et al. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease [J]. Stroke, 2010, 41(3): 450-454.
18
Molad J, Kliper E, Korczyn AD, et al. Only white matter hyperintensities predicts post-stroke cognitive performances among cerebral small vessel disease markers: results from the TABASCO study [J]. J Alzheimers Dis, 2017, 56(4): 1293-1299.
19
Xia Y, Shen Y, Wang Y, et al. White matter hyperintensities associated with progression of cerebral small vessel disease: a 7-year Chinese urban community study [J]. Aging, 2020, 12(9): 8506-8522.
20
Ding J, Sigurðsson S, Jónsson PV, et al. Large perivascular spaces visible on magnetic resonance imaging, cerebral small vessel disease progression, and risk of dementia: the age, gene/environment susceptibility-Reykjavik study [J]. JAMA Neurol, 2017, 74(9): 1105-1112.
21
Paradise M, Crawford JD, Lam BCP, et al. Association of dilated perivascular spaces with cognitive decline and incident dementia [J]. Neurology, 2021, 96(11): e1501-e1511.
22
Lau KK, Li L, Schulz U, et al. Total small vessel disease score and risk of recurrent stroke: validation in 2 large cohorts [J]. Neurology, 2017, 88(24): 2260-2267.
23
Gregoire SM, Chaudhary UJ, Brown MM, et al. The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds [J]. Neurology, 2009, 21(73): 1759-1766.
24
Charidimou A, Turc G, Oppenheim C, et al. Microbleeds, cerebral hemorrhage, and functional outcome after stroke thrombolysis [J]. Stroke, 2017, 48(8): 2084-2090.
25
胡文立, 杨磊, 李譞婷, 等. 中国脑小血管病诊治专家共识2021 [J]. 中国卒中杂志, 2021, 16(7): 716-726.
26
Yang S, Yuan J, Qin W, et al. Twenty-four-hour ambulatory blood pressure variability is associated with total magnetic resonance imaging burden of cerebral small-vessel disease [J]. Clin Interv Aging, 2018, 13: 1419-1427.
27
Thong JYJ, Hilal S, Wang Y, et al. Association of silent lacunar infarct with brain atrophy and cognitive impairment [J]. J Neurol Neurosurg Psychiatry, 2013, 84(11): 1219-1225.
28
Jokinen H, Lipsanen J, Schmidt R, et al. Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS study [J]. Neurology, 2012, 78(22): 1785-1792.
29
Rhodius-Meester HFM, Benedictus MR, Wattjes MP, et al. MRI visual ratings of brain atrophy and white matter hyperintensities across the spectrum of cognitive decline are differently affected by age and diagnosis [J]. Front Aging Neurosci, 2017, 9: 117.
30
Kim YJ, Kwon HK, Lee JM, et al. Gray and white matter changes linking cerebral small vessel disease to gait disturbances [J]. Neurology, 2016, 86(13): 1199-1207.
31
Charidimou A, Martinez-Ramirez S, Reijmer YD, et al. Total magnetic resonance imaging burden of small vessel disease in cerebral amyloid angiopathy: an imaging-pathologic study of concept validation [J]. JAMA Neurol, 2016, 73(8): 994-1001.
32
Charidimou A, Imaizumi T, Moulin S, et al. Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: a meta-analysis [J]. Neurology, 2017, 89(8): 820-829.
33
Li Q, Zanon Zotin MC, Warren AD, et al. CT-visible convexity subarachnoid hemorrhage is associated with cortical superficial siderosis and predicts recurrent ICH [J]. Neurology, 2021, 96(7): e986-e994.
34
Staals J, Makin SDJ, Doubal FN, et al. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden [J]. Neurology, 2014, 83(14): 1228-1234.
35
Xu Z, Li F, Xing D, et al. A novel imaging biomarker for cerebral small vessel disease associated with cognitive impairment: the deep-medullary-veins score [J]. Front Aging Neurosci, 2021, 13: 720481.
36
李譞婷, 胡文立. 脑小血管病影像学标志物之间关联性研究的进展 [J/CD]. 中华脑血管病杂志(电子版), 2021, 15(4): 218-221.
[1] 常文轩, 王婷, 刘伟, 蓝天琦, 彭静, 汪诗瑶, 张晓鹏, 冯晨, 宫雪梅, 朱敏. 脑小血管病所致执行障碍的研究进展[J]. 中华消化病与影像杂志(电子版), 2023, 13(03): 179-182.
[2] 丁文华, 王育伟, 邱景景, 杨琼, 耿玉荣. 脑小血管病影像学标志物与运动障碍研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 429-434.
[3] 白明悦, 杨淑娜, 胡红梅, 胡文立. 透析患者脑小血管病患病情况的研究现状及其机制探讨[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 505-509.
[4] 晏美娟, 邵礼晖. 高水平脂蛋白(a)与无“三高”老年人群小动脉硬化型脑小血管病的相关性研究[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 458-463.
[5] 刘琳, 张奇山, 廖蔓倩, 陈余榕, 李倍, 何玉成, 唐圣桃. HTRA1相关常染色体显性脑小血管病家系报告并文献复习[J]. 中华脑血管病杂志(电子版), 2023, 17(04): 379-385.
[6] 王道合, 施媛媛. 8-iso-PGF2α及P选择素在评估脑小血管病患者认知功能中的价值[J]. 中华脑血管病杂志(电子版), 2023, 17(04): 364-368.
[7] 李卓然, 胡文立. 内皮功能、炎症、神经系统退行性疾病的生物标志物与小动脉硬化型CSVD的关联[J]. 中华脑血管病杂志(电子版), 2023, 17(01): 57-60.
[8] 张兴文, 侯磊, 冉晔, 田成林. 急性多发性缺血性脑小血管病10例临床分析[J]. 中华脑血管病杂志(电子版), 2023, 17(01): 22-25.
[9] 刘欣, 王丽娟, 刘荧, 王爽, 徐绍红, 李小刚. 缺血性脑卒中后不同程度认知障碍危险因素及认知训练效果分析[J]. 中华脑血管病杂志(电子版), 2022, 16(05): 314-319.
[10] 祁林瑞, 曾嵘, 胡风云. 炎性及代谢指标与脑小血管病认知障碍的相关性[J]. 中华脑血管病杂志(电子版), 2022, 16(01): 32-37.
[11] 晏僖, 尚俊奎, 王凤羽, 秦晓明, 霍雪静, 刘锐杰, 邹金龙, 张杰文. 同型半胱氨酸及凝血-纤溶指标与脑小血管病的关系[J]. 中华脑血管病杂志(电子版), 2022, 16(01): 27-31.
[12] 胡红梅, 胡文立. 不同空间分布脑微出血的常见病因和影像学特征的研究进展[J]. 中华脑血管病杂志(电子版), 2022, 16(01): 8-11.
[13] 洪靖舒, 韩登阳, 郭向阳. 神经血管单元在脑小血管病中的研究进展[J]. 中华脑血管病杂志(电子版), 2022, 16(01): 48-52.
[14] 张蓉, 赵晨阳, 何志义. 不同影像学表现的脑小血管病所致认知障碍特点的研究进展[J]. 中华脑血管病杂志(电子版), 2022, 16(01): 44-47.
[15] 田丹阳, 唐雯, 樊东升. 腹膜透析患者脑小血管病患病状况分析[J]. 中华脑血管病杂志(电子版), 2021, 15(04): 232-236.
阅读次数
全文


摘要